Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johnson & Johnson Surgical Vision, Inc.
The next generation TECNIS IOL designed to provide improved intermediate and near visual acuity and decreased spectacle wear was evaluated for safety and effectiveness in a six-month interventional study and compared to a marketed monofocal IOL. Assessments included distance-corrected intermediate and near visual acuity, depth of focus at 0.2 logMAR and spectacle wear frequency.
Age
22–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Minimum 22 years of age
Bilateral cataracts for which posterior chamber IOL implantation has been planned
Corneal astigmatism:
Normal corneal topography
Availability, willingness and sufficient cognitive awareness to comply with examination procedures and study visits
Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
Ability to understand and respond to a questionnaire in English
You may not be if
Irregular corneal astigmatism
Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
Prior corneal refractive (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery, Including prophylactic peripheral iridotomies and peripheral laser retinal repairs
Poorly-controlled diabetes
Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
Concurrent participation or participation within 60 days prior to preoperative visit in any other clinical trial
Desire for monovision correction
Clareo Health | Clinical Investigation of the Next Generation Intraocular Lens
